Cost-effectiveness of Evolocumab in Cardiovascular Disease: A Systematic Review
Background: With the rising burden of cardiovascular disease (CVD) and the need for cost-effective interventions, evaluating the economic implications of Evolocumab becomes crucial. Objectives: This study aimed to systematically review and evaluate the cost-effectiveness of Evolocumab in adults at r...
Saved in:
| Main Authors: | Nashmil Ghadimi, Rajabali Daroudi, Hosein Shabaninejad, Mahshad Goharimehr, Davoud Khodamorzideh, Sara Kaveh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-01-01
|
| Series: | Current Therapeutic Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0011393X24000286 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EXPERIENCE WITH THE USE OF EVOLOCUMAB THERAPY IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (IN KARELIA REPUBLIC)
by: V. A. Korneva, et al.
Published: (2020-06-01) -
Evolocumab safety and efficacy in hypercholesterolemia patients with or without diabetes: a retrospective real-world analysis
by: Sultan Ibrahim Alraddadi, et al.
Published: (2025-01-01) -
Cost-effectiveness of evolocumab in treatment of heterozygous familial hypercholesterolaemia in Bulgaria: measuring health benefit by effectively treated patient-years*
by: Borislav Borissov, et al.
Published: (2017-01-01) -
Effects of Alirocumab and Evolocumab on Cardiovascular Mortality and LDL-C: Stratified According to the Baseline LDL-C Levels
by: Hui Ma, et al.
Published: (2025-04-01) -
Evolocumab Reduces Oxidative Stress and Lipid Peroxidation in Obese Zucker Rats
by: Martina Cebova, et al.
Published: (2025-01-01)